Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease
- 1 January 1992
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 13 (1) , 107-113
- https://doi.org/10.1016/0197-4580(92)90017-r
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer typeActa Neurologica Scandinavica, 2009
- Loss of Dopamine Uptake Sites Labeled with [3H]GBR-12935 in Alzheimer’s DiseaseEuropean Neurology, 1990
- CSF monoamine metabolites in dementia of the Alzheimer type and controls: Evidence for lower levels of homovanillic acid and 5‐hydroxyindoleacetic acid in patientsInternational Journal of Geriatric Psychiatry, 1988
- Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute strokeActa Neurologica Scandinavica, 1987
- Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementiaActa Psychiatrica Scandinavica, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluidJournal of Neurology, Neurosurgery & Psychiatry, 1973
- On the origin of homovanillic acid (HVA) in the cerebrospinal fluidJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
- 5-Hydroxyindoleacetic acid in spinal fluid: relative contribution from brain and spinal cordBrain Research, 1973
- Estimation of 5-hydroxytryptamine (5-HT) level in cerebrospinal fluid of patients with intracranial or spinal lesions.Journal of Neurology, Neurosurgery & Psychiatry, 1967